Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD10 intronic transcript 1 (ANKRD10-IT1) is a human long non-coding RNA gene located within an intronic region of the protein-coding ANKRD10 gene.[2][4] It does not encode a protein and is not classified as a therapeutic target, such as a receptor, enzyme, transporter, or transcription factor. The specific biological function of ANKRD10-IT1 remains largely uncharacterized, though it may play a regulatory role in gene expression at the RNA level, as is common for lncRNAs. Disease associations are limited, but there are some links to retinitis pigmentosa[4]. There is no evidence for direct interaction with drugs, biomarker status, or documented safety concerns in the current literature. "ANKRD10-IT1" is not the same as the ANKRD10 protein or its protein isoforms, which have different biological properties and classifications[1][3][6][7]. ANKRD10-IT1 is a non-coding RNA and does not have therapeutic targeting attributes typically ascribed to protein-coding genes or classical receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANKRD10 intronic transcript 1 (ANKRD10-IT1).